1 Min Read
May 4 (Reuters) - Mallinckrodt Plc
* First patient enrolled in Mallinckrodt phase 2 trial of Stratagraft® regenerative skin tissue
* Mallinckrodt Plc- Study completion is expected by late 2018 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.